A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder

NCT02234011 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Terminated due to difficulty in recruiting participants.

Conditions

Obsessive-Compulsive Disorder

Interventions

DRUG: Ketamine
DRUG: Placebo

Sponsor

Mclean Hospital